Vr Adviser, LLC Instil Bio, Inc. Transaction History

Vr Adviser, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 15, 2023	SELL	$4.65 - $7.37 $8.8 Million - $13.9 Million	-1,891,878 Reduced 31.54%	4,105,779 $19.9 Million
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $8.8 Million - $13.9 Million	-1,891,878 Reduced 31.54%	4,105,779 $19.9 Million
Q2 2022 May 15, 2023	BUY	$4.21 - $11.15 $25.3 Million - $66.9 Million	5,997,657 New	5,997,657 $27.7 Million
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $3.65 Million - $9.67 Million	-867,419 Reduced 12.64%	5,997,657 $27.7 Million
Q1 2021 May 14, 2021	BUY	$24.23 - $27.06 $166 Million - $186 Million	6,865,076 New	6,865,076 $172 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.